Peter Attia· MD
in gosh it might have been 2013-14 a very interesting study was published called predimed which we'll spend a minute on and it was interesting in that it was a clinical trial it had three arms and it relied on hard outcomes hard outcomes meaning mortality or morbidity of some sort rather than just soft outcomes like a biomarker if you had told me before the results came out this is the study you're going to have a low-fat arm and two mediterranean arms that are going to be split this way in this way and we're going to be looking at primary prevention i would have said the likelihood you'll see a difference in these three groups is quite low because it just didn't strike me as a very robust design but i guess to the author's credit they had selected people that were sick enough that within you know i think they had planned to go as long as seven or so years but under five years they ended up stopping the study given that the two arms in the mediterranean arm one that was randomized to receive olive oil the other i believe received nuts performed significantly better than the low-fat arm